Global Autoimmune and Inflammatory Immunomodulators Market 2016-2020


#867646

98pages

Technavio

$ 2500

In Stock

About Autoimmune and Inflammatory Immunomodulators

Immunomodulators are the drugs that help to regulate the immune system. These drugs either stimulate the weak immune systems or moderate the overactive immune systems. Though many drugs are available in the market, there still exists a huge unmet need in the autoimmune and inflammatory immunomodulators market as there are no medicines that provide complete cure to some diseases such as rheumatoid arthritis, ulcerative colitis, and Crohns disease.

Technavios analysts forecast the global autoimmune and inflammatory immunomodulators market to grow at a CAGR of 7.01% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global autoimmune and inflammatory immunomodulators market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Autoimmune and Inflammatory Immunomodulators Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
AbbVie
Johnson & Johnson
Amgen
F. Hoffmann-La Roche
Pfizer

Other prominent vendors
AstraZeneca
Avaxia Biologics
Biogen Idec
Bristol-Myers Squibb
Boehringer Ingelheim
Eli Lilly
Enlivex Therapeutics
Gilead Sciences
Immune Pharmaceuticals
Merck
Mitsubishi Tanabe Pharma
Neovacs
Prometheus Laboratories
Sandoz
Sanofi
Swedish Orphan Biovitrum
Takeda Pharmaceuticals
UCB

Market driver
Development of novel therapies using innovative technologies.
For a full, detailed list, view our report

Market challenge
Discontinuation of drugs under development leading to substantial loss in revenue.
For a full, detailed list, view our report

Market trend
Advent of biosimilars expected to improve the treatment rates.
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.